Markus Hoffmann
Impact in
- Infectious Diseases top 0.01%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
- Neurology top 0.2%
- Long-Term Effects of COVID-19
Papers in
-
- SARS-CoV-2 and COVID-19 Research 118
- COVID-19 Clinical Research Studies 57
- SARS-CoV-2 detection and testing 19
- Viral Infections and Vectors 16
- Viral Infections and Outbreaks Research 16
- Viral gastroenteritis research and epidemiology 12
-
- Animal Virus Infections Studies 25
- Co-authors
- Stefan Pöhlmann (116 shared papers)Hannah Kleine‐Weber (11 shared papers)Nadine Krüger (26 shared papers)Christian Drosten (19 shared papers)Marcel A. Müller (14 shared papers)Simon Schroeder (3 shared papers)Georg Herrler (11 shared papers)Nai‐Huei Wu (1 shared paper)
- Journals
- The Lancet Infectious Diseases (16 papers)Journal of Virology (15 papers)Cellular and Molecular Immunology (8 papers)Nature Communications (8 papers)PLoS ONE (8 papers)
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Markus Hoffmann
171 papers receiving 24.0k citations
Markus Hoffmann's Hit Papers
Peers
Comparison fields: 5 of 186
- Infectious Diseases 17.2k
- Neurology 3.6k
- Animal Science and Zoology 1.6k
- Obstetrics and Gynecology 1.0k
- Immunology 2.4k
Countries citing papers authored by Markus Hoffmann
This map shows the geographic impact of Markus Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Hoffmann more than expected).
Fields of papers citing papers by Markus Hoffmann
This network shows the impact of papers produced by Markus Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Hoffmann. The network helps show where Markus Hoffmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 177 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Hit paper breakdown → | 2020 | 14969 |
| 2 | A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells Hit paper breakdown → | 2020 | 1380 |
| 3 | The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic Hit paper breakdown → | 2021 | 697 |
| 4 | SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies Hit paper breakdown → | 2021 | 687 |
| 5 | 2020 | 486 | |
| 6 | 2020 | 385 | |
| 7 | 2020 | 337 | |
| 8 | Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination Hit paper breakdown → | 2021 | 334 |
| 9 | Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity Hit paper breakdown → | 2021 | 282 |
| 10 | 2021 | 196 | |
| 11 | 2021 | 176 | |
| 12 | 2020 | 164 | |
| 13 | 2020 | 157 | |
| 14 | 2018 | 120 | |
| 15 | 2022 | 119 | |
| 16 | 2020 | 117 | |
| 17 | 2021 | 108 | |
| 18 | 2018 | 105 | |
| 19 | 2004 | 103 | |
| 20 | 2020 | 100 |
About Markus Hoffmann
Markus Hoffmann is a scholar working on Infectious Diseases, Animal Science and Zoology, Epidemiology, Immunology and Virology, having authored 177 papers that have together received 24.5k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (118 papers), COVID-19 Clinical Research Studies (57 papers), Animal Virus Infections Studies (25 papers), SARS-CoV-2 detection and testing (19 papers), Viral Infections and Vectors (16 papers), Viral Infections and Outbreaks Research (16 papers), Virology and Viral Diseases (14 papers) and Viral gastroenteritis research and epidemiology (12 papers). The work is most often cited by research in Infectious Diseases (17.2k citations), Neurology (3.6k citations), Animal Science and Zoology (1.6k citations), Obstetrics and Gynecology (1.0k citations) and Immunology (2.4k citations). Markus Hoffmann has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Stefan Pöhlmann, Hannah Kleine‐Weber, Nadine Krüger, Christian Drosten, Marcel A. Müller, Simon Schroeder, Georg Herrler, Nai‐Huei Wu, Andreas Nitsche and Tobias S. Schiergens. Their work appears in journals such as The Lancet Infectious Diseases, Journal of Virology, Cellular and Molecular Immunology, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.